[1]
P.K. Gupta et al., A metal-free tandem approach to prepare structurally diverse N-heterocycles: synthesis of 1,2,4-oxadiazoles and pyrimidinones, New. J. Chem. 38 (2014) 3062-3070.
DOI: 10.1039/c4nj00361f
Google Scholar
[2]
R. Kharb, R. Kaur, A.K. Sharma, Vistas on antimicrobial potential of novel oxadiazole derivatives in modern medicinal chemistry, European Journal of Biomedical and Pharmaceutical Sciences. 1(2) (2014) 401-420.
Google Scholar
[3]
S. Distinto et al., Drug design, synthesis, in vitro and in silico evaluation of selective monoaminoxidase B inhibitors based on 3-acetyl-2-dichlorophenyl-5-aryl-2,3-dihydro-1,3,4-oxadiazole chemical scaffold, Eur. J. Med. Chem. 108 (2016) 542-552.
DOI: 10.1016/j.ejmech.2015.12.026
Google Scholar
[4]
R.S. Kumar et al., Anti-inflammatory and antimicrobial activities of novel pyrazole analogues, Saudi. J. Biol. Sci. 23 (2016) 614-620.
DOI: 10.1016/j.sjbs.2015.07.005
Google Scholar
[5]
D.S. Musmade, S.R. Pattan, S.Y. Manjunath, Oxadiazole a nucleus with versatile biological behaviour, Int. J. Pharm. Chem. 2015.
DOI: 10.7439/ijpc
Google Scholar
[6]
D. Allison et al., Synthesis and antimicrobial studies of novel derivatives of 4-(4-formyl-3-phenyl-1H-pyrazol-1-yl)benzoic acid as potent anti-Acinetobacter baumannii agents, Bioorg. Med. Chem. Lett. 27 (2017) 387-392.
DOI: 10.1016/j.bmcl.2016.12.068
Google Scholar
[7]
H. Cheng et al., Synthesis and SAR of heteroaryl-phenyl-substituted pyrazole derivatives as highly selective and potent canine COX-2 inhibitors, Bioorg. Med. Chem. Lett. 16 (2006) 2076-2080.
DOI: 10.1002/chin.200629123
Google Scholar
[8]
M.A.F. Vera-DiVaio et al., Synthesis, antichagasic in vitro evaluation, cytotoxicity assays, molecular modeling, and SAR/QSAR studies of a 2-phenyl-3-(1-phenyl-1H-pyrazol-4-yl)-acrylic acid benzylidene-carbohydrazide series, Bioorg. Med. Chem. 17 (2009) 295.
DOI: 10.1016/j.bmc.2008.10.085
Google Scholar
[9]
B.P. Chetan, V.V. Mulwar, Synthesis and evaluation of certain pyrazolines and related compounds for their anti tubercular, antibacterial and anti fungal activities, Ind. J. Chem. 44B (2000) 232-237.
Google Scholar
[10]
R.H. Udupi, A.R. Bhat, K. Krishna, Synthesis and investigation of some new pyrazoline derivatives for their antimicrobial, anti inflammatory and analgesic activities, Ind. J. Heterocycle. Chem. 8 (1998) 143-146.
Google Scholar
[11]
R.S. Fabiane et al., Hypothermic and antipyretic effects of 3-methyl- and 3-phenyl-5-hydroxy-5-trichloromethyl-4,5-dihydro-1H-pyrazole-1-carboxyamides in mice, Eur. J. Pharmacol. 451(2) (2002) 141-147.
DOI: 10.1016/s0014-2999(02)02225-2
Google Scholar
[12]
K. Ashok, A.S. Sharma, Synthesis of potential quinazolinyl pyrazolines as anticonvulsant agents, Ind. J. Hetero. Chem. 9 (2001) 197.
Google Scholar
[13]
P. Zoumpoulakis et al., Synthesis of novel sulfonamide-1,2,4-triazoles, 1,3,4-thiadiazoles and 1,3,4-oxadiazoles, as potential antibacterial and antifungal agents. Biological evaluation and conformational analysis studies, Bioorg. Med. Chem. 20 (2012) 1569-1583.
DOI: 10.1016/j.bmc.2011.12.031
Google Scholar
[14]
D. Sriram, D. Banerjee, P.J. Yogeeswari, Efavirenz Mannich bases: Synthesis, anti-HIV and antitubercular activities, J. Enzyme. Inhib. Med. Chem. 24(1) (2009) 1-5.
DOI: 10.1080/14756360701404159
Google Scholar
[15]
A.S. Aboraia et al., Novel 5-(2-hydroxyphenyl)-3-substituted-2,3-dihydro-1,3,4-oxadiazole-2-thione derivatives: promising anticancer agents, Bioorg. Med. Chem. 14 (2006) 1236.
DOI: 10.1016/j.bmc.2005.09.053
Google Scholar
[16]
A. Zarghi et al., Synthesis and anticonvulsant activity of new 2-substituted-5-(2-benzyloxyphenyl)-1,3,4-oxadiazoles, Bioorg. Med. Chem. Lett. 15 (2005) 1863-1865.
Google Scholar
[17]
R.A. Rane et al., Synthesis and evaluation of novel 4-nitropyrrole-based 1,3,4-oxadiazole derivatives as antimicrobial and anti-tubercular agents, Eur. J. Med. Chem. 70 (2013) 49-58.
DOI: 10.1016/j.ejmech.2013.09.039
Google Scholar
[18]
T.M. Kadayat et al., Modified 2,4-diaryl-5H-indeno[1,2-b]pyridines with hydroxyl and chlorine moiety: Synthesis, anticancer activity, and structure-activity relationship study, Bioorg. Chem. 62 (2015) 30-40.
DOI: 10.1016/j.bioorg.2015.07.002
Google Scholar
[19]
R.M. Mohareb, M.Y. Zaki, N.S. Abbas, Synthesis, anti-inflammatory and anti-ulcer evaluations of thiazole, thiophene, pyridine and pyran derivatives derived from and rostenedione, Steroids. 98 (2015) 80-91.
DOI: 10.1016/j.steroids.2015.03.001
Google Scholar
[20]
G. Jose et al., Synthesis, crystal structure, molecular docking and antimicrobial evaluation of new pyrrolo [3,2-c] pyridine derivatives, J. Mol. Struct. 1081 (2015) 85-95.
DOI: 10.1016/j.molstruc.2014.10.006
Google Scholar
[21]
V.K. Vladimir, G.B. Alicia, Recent developments in the design and synthesis of hybrid molecules base donaminoquinoline ring and their antiplasmodial evaluation, Eur. J. Med. Chem. 44 (2009) 3091-3113.
Google Scholar
[22]
N.C. Desai et al., Synthesis and antibacterial and cytotoxic activities of new N-3 substituted thiazolidine-2,4-dione derivatives bearing the pyrazole moiety, Arch. Pharm. Chem. Life. Sci. 347(7) (2014) 1-10.
DOI: 10.1002/ardp.201300466
Google Scholar
[23]
N.C. Desai, M.J. Bhatt, Optimized synthesis of novel pyrazole based thiazole derivatives and their antimicrobial evaluation, Int. Lett. Chem. Phys. Astron. 66 (2016) 109-118.
DOI: 10.56431/p-i63g13
Google Scholar
[24]
N.C. Desai et al., Synthesis, characterization and antimicrobial screening of hybrid molecules containing benzimidazole-pyrazole and pyridine nucleus, Med. Chem. Res. 21 (2012) 4463-4472.
DOI: 10.1007/s00044-012-9990-4
Google Scholar
[25]
N.C. Desai et al., Dimeric 2-(2-chlorophenyl)-quinazolin-4-ones as potential antimicrobial agents, Med. Chem. Res. 21 (2012) 1127-1135.
DOI: 10.1007/s00044-011-9621-5
Google Scholar
[26]
N.C. Desai, G.M. Kotadiya, Facile synthesis of pyrazole encompassing pyridyl oxadiazole using conventional and microwave techniques, Curr. Org. Chem. 18 (2014) 2561-2570.
DOI: 10.2174/138527281819141028114856
Google Scholar
[27]
P.C. Hannan, Guidelines and recommendations for antimicrobial minimum inhibitory concentration (MIC) testing against veterinary mycoplasma species, Vet. Res. 31 (2000) 373-395.
DOI: 10.1051/vetres:2000100
Google Scholar
[28]
N.C. Desai et al., Synthesis, antimicrobial and cytotoxic activities of some novel thiazole clubbed 1,3,4-oxadiazoles, Eur. J. Med. Chem. 67 (2013) 54-59.
DOI: 10.1016/j.ejmech.2013.06.029
Google Scholar
[29]
A. Rattan, Antimicrobials in laboratory medicine, B.I. Churchill Livingstone, New Delhi, 2000, pp.85-108.
Google Scholar